Non-ownership Filings
| GSK US Investment Announcement | Sep. 17, 2025 |
| Total Voting Rights | Sep. 01, 2025 |
| FDA to review gonorrhea indication for gepotidacin | Aug. 11, 2025 |
| CureVac/BioNTech mRNA patent litigation settlement | Aug. 08, 2025 |
| Total Voting Rights | Aug. 01, 2025 |
| 2nd Quarter Results | Jul. 30, 2025 |
| GSK enters Hengrui Pharma collaboration agreements | Jul. 28, 2025 |
Ownership Update Filings
| Transaction in Own Shares | Sep. 18, 2025 |
| Transaction in Own Shares | Sep. 17, 2025 |
| Transaction in Own Shares | Sep. 16, 2025 |
| Transaction in Own Shares | Sep. 15, 2025 |
| Transaction in Own Shares | Sep. 11, 2025 |
| Director/PDMR Shareholding | Sep. 10, 2025 |
| Transaction in Own Shares | Sep. 10, 2025 |